| Dr Jacob Harry Koffer, MD | |
|
1200 W Tabor Rd Ste 145, Philadelphia, PA 19141-3019 | |
| (215) 456-9475 | |
| (215) 456-9529 |
| Full Name | Dr Jacob Harry Koffer |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 1200 W Tabor Rd Ste 145, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104310952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MT215162 (Pennsylvania) | Primary |
| Entity Name | Einstein Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760434468 PECOS PAC ID: 2769395896 Enrollment ID: O20040219000728 |
News Archive
The FDA inspected 0.7 percent of foreign clinical drug trial sites in 2008 while 80 percent of applications approved for marketing that year contained data from foreign drug trials, according to a report (.pdf) from the Inspector General of HHS, CBS News reports (Strickler, 6/22).
PharmaNet Development Group, and Anapharm Europe, S.L., both leading providers of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announced that their joint venture for the collaborative provision of bioanalytical services officially ended December 22, 2010.
Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.
Today, Molecular Devices, Inc.—now part of Danaher Corporation—re-launched the Molecular Devices brand into the life sciences marketplace. The renewed corporate brand is focused primarily on meeting customer needs and exceeding customer expectations, and includes an evolved visual identity system.
Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jacob Harry Koffer, MD 101 E Olney Ave Ste 400, Philadelphia, PA 19120-2470 Ph: (215) 456-7000 | Dr Jacob Harry Koffer, MD 1200 W Tabor Rd Ste 145, Philadelphia, PA 19141-3019 Ph: (215) 456-9475 |
News Archive
The FDA inspected 0.7 percent of foreign clinical drug trial sites in 2008 while 80 percent of applications approved for marketing that year contained data from foreign drug trials, according to a report (.pdf) from the Inspector General of HHS, CBS News reports (Strickler, 6/22).
PharmaNet Development Group, and Anapharm Europe, S.L., both leading providers of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announced that their joint venture for the collaborative provision of bioanalytical services officially ended December 22, 2010.
Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.
Today, Molecular Devices, Inc.—now part of Danaher Corporation—re-launched the Molecular Devices brand into the life sciences marketplace. The renewed corporate brand is focused primarily on meeting customer needs and exceeding customer expectations, and includes an evolved visual identity system.
Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.
› Verified 7 days ago
Mikhail Freylikh, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 12033 Bustleton Ave, Philadelphia, PA 19116 Phone: 215-671-8840 Fax: 215-671-1933 | |
Dr. Peggy Lynn Abrams, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1531 Spruce St, Philadelphia, PA 19102 Phone: 215-546-1591 | |
Lindsay Gerringer, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8015 Frankford Ave, Philadelphia, PA 19136 Phone: 215-338-8900 | |
John Whyte, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 101 E Olney Ave, Suite 400, Philadelphia, PA 19120 Phone: 215-456-7000 Fax: 215-254-2599 | |
Curtis W Slipman, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce Street, 1 Ground White Bldg, Philadelphia, PA 19104 Phone: 215-662-3261 | |
Dr. Patrick M. Rommel, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1513 Race St, Philadelphia, PA 19102 Phone: 215-587-3056 Fax: 215-587-9405 | |
Dr. Deborah J. Franklin, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 25 S 9th St, Dept. Of Rehabilitation Medicine, Philadelphia, PA 19107 Phone: 215-955-6698 |